Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06571487

Growth Hormone Resistance of Beta-cells

Growth Hormone Resistance of Beta-cells in Women With Gestational Diabetes Mellitus

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a personal history of gestational diabetes (high blood sugar in pregnancy) at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing gestational diabetes and type 2 diabetes.

Conditions

Timeline

Start date
2025-10-22
Primary completion
2028-09-01
Completion
2030-09-01
First posted
2024-08-26
Last updated
2025-11-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06571487. Inclusion in this directory is not an endorsement.

Growth Hormone Resistance of Beta-cells (NCT06571487) · Clinical Trials Directory